Proteolytic Degradation Is a Major Contributor to Bioprosthetic Heart Valve Failure

Proteolytic Degradation Is a Major Contributor to Bioprosthetic Heart Valve Failure

Background Whereas the risk factors for structural valve degeneration (SVD) of glutaraldehyde‐treated bioprosthetic heart valves (BHVs) are well studied, those responsible for the failure of BHVs fixed with alternative next‐generation chemicals remain largely unknown. This study aimed to investigate...

Full description

Bibliographic Details
Main Authors:	Alexander E. Kostyunin, Tatiana V. Glushkova, Arseniy A. Lobov, Evgeny A. Ovcharenko, Bozhana R. Zainullina, Leo A. Bogdanov, Daria K. Shishkova, Victoria E. Markova, Maksim A. Asanov, Rinat A. Mukhamadiyarov, Elena A. Velikanova, Tatiana N. Akentyeva, Maria A. Rezvova, Alexander N. Stasev, Alexey V. Evtushenko, Leonid S. Barbarash, Anton G. Kutikhin
Format:	Article
Language:	English
Published:	Wiley 2023-01-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	bacterial invasion bioprosthetic heart valves matrix metalloproteinases neutrophil infiltration structural valve degeneration
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.122.028215

Similar Items

Embedding and Backscattered Scanning Electron Microscopy (EM-BSEM) Is Preferential over Immunophenotyping in Relation to Bioprosthetic Heart Valves
by: Alexander Kostyunin, et al.
Published: (2023-09-01)

Early Postoperative Immunothrombosis of Bioprosthetic Mitral Valve and Left Atrium: A Case Report
by: Alexander Kostyunin, et al.
Published: (2022-06-01)

Ultrastructural Pathology of Atherosclerosis, Calcific Aortic Valve Disease, and Bioprosthetic Heart Valve Degeneration: Commonalities and Differences
by: Alexander Kostyunin, et al.
Published: (2020-10-01)

Modern understanding of mechanisms of bioprosthetic valve structural degeneration: a literature review
by: A. E. Kostyunin, et al.
Published: (2018-12-01)

Expression of matrix metalloproteinases 1, 2, 9, 12 in xenogenic tissues of epoxy-crosslinked bioprosthetic heart valves explanted due to dysfunction
by: A. E. Kostyunin, et al.
Published: (2020-11-01)

A case report of bioprosthetic valve dysfunction after tricuspid valve replacement in a preschool patient: the contribution of pannus and calcification
by: T. V. Glushkova, et al.
Published: (2018-09-01)

Degeneration of Bioprosthetic Heart Valves: Update 2020
by: Alexander E. Kostyunin, et al.
Published: (2020-10-01)

Expression of tissue inhibitors of metalloproteinases type 1 and type 2 in the leaflets of explanted bioprosthetic heart valves: a new pathogenetic parallel between structural valve degeneration and calcific aortic stenosis
by: A. E. Kostyunin, et al.
Published: (2021-09-01)

Noncalcific Mechanisms of Bioprosthetic Structural Valve Degeneration
by: Matteo Marro, et al.
Published: (2021-02-01)

India’s first percutaneous tricuspid valve implantation: Valve-in-valve is a treatment option for bioprosthetic valve dysfunction
by: A.B. Gopalamurugan, et al.
Published: (2017-05-01)

Imaging of Bioprosthetic Valve Dysfunction after Transcatheter Aortic Valve Implantation
by: Louhai Alwan, et al.
Published: (2023-05-01)

Effects of short-term oral anticoagulation following surgical bioprosthetic aortic valve replacement
by: Tsung-Yu Ko, et al.
Published: (2023-01-01)

Transcatheter heart valve in valve implantation with Edwards SAPIEN bioprosthetic valve for different degenerated bioprosthetic valve positions (First Iranian ViV report with mid-term follow up)
by: Ali Mohammad Haji Zeinali, et al.
Published: (2017-09-01)

Trans-Catheter Valve-in-Valve Implantation for the Treatment of Aortic Bioprosthetic Valve Failure
by: Andrea Buono, et al.
Published: (2022-01-01)

Coronary embolism due to probable clinical bioprosthetic aortic valve thrombosis: a case report
by: Roshan A Ananda, et al.
Published: (2023-06-01)

Factors Influencing Mortality after Bioprosthetic Valve Replacement; A Midterm Outcome
by: Hassan Javadzadegan, et al.
Published: (2013-12-01)

Acute valve malfunction with thrombosed bioprosthetic valve after surgical aortic valve replacement
by: Hiroki Moriuchi, et al.
Published: (2023-10-01)

A case of Candida parapsilosis bioprosthetic valve endocarditis
by: Kenji Sakakibara, et al.
Published: (2023-02-01)

Biochemical and histological evidence of deteriorated bioprosthetic valve leaflets: the accumulation of fibrinogen and plasminogen
by: Tomohisa Sakaue, et al.
Published: (2018-08-01)

A Genomics-Based Model for Prediction of Severe Bioprosthetic Mitral Valve Calcification
by: Anastasia V. Ponasenko, et al.
Published: (2016-08-01)

Long-Term Outcomes of Bioprosthetic and Mechanical Valve Replacement for Patients Aged between 50 and 70 Years
by: Wei Zhao, et al.
Published: (2023-09-01)

Bioprosthetic Valve Fracturing: In vitro Testing of Edwards PERIMOUNT Model P 2900
by: Hendrik Ruge, et al.
Published: (2022-06-01)

A Case of Bioprosthetic Valve Thrombosis: Is it Time to Revise Our Thinking?
by: Ramkumar Rajappan, et al.
Published: (2022-01-01)

A rare case report of early bioprosthetic valve thrombosis presenting with acute heart failure salvaged by thrombectomy
by: Jingya Fan, et al.
Published: (2017-03-01)

Reversal of Bioprosthetic Aortic Valve Thrombosis Using Rivaroxaban—A Case Report
by: Harish Sharma, et al.
Published: (2020-05-01)

Bioprosthetic Aortic Valve Thrombosis and Literature Review
by: Milan Radovanovic, et al.
Published: (2022-08-01)

Residual Bioprosthetic Valve Immunogenicity: Forgotten, Not Lost
by: Paul Human, et al.
Published: (2022-01-01)

Degenerated bioprosthetic mitral valve thrombosis as a rare cause of cardiac source of thromboembolism
by: Macit Kalcik, et al.
Published: (2014-07-01)

Functional assessment of bioprosthetic mitral valves by cardiovascular magnetic resonance: An in vitro validation and comparison to Doppler echocardiography
by: Dimitrios Maragiannis, et al.
Published: (2020-07-01)

Mechanisms and Drug Therapies of Bioprosthetic Heart Valve Calcification
by: Shuyu Wen, et al.
Published: (2022-06-01)

Circulating Progenitor Cells Are Associated With Bioprosthetic Aortic Valve Deterioration: A Preliminary Study
by: Yoshihisa Kanaji, et al.
Published: (2023-01-01)

Is this the beginning of end for warfarin in bioprosthetic mitral valve recipients with atrial fibrillation? – New insights from RIVER trial
by: Ankit Kumar Sahu, et al.
Published: (2021-07-01)

Anesthetic management for patient with severe cyanosis following bioprosthetic valve stenosis
by: Jun Zeng, et al.
Published: (2019-04-01)

Trans-catheter Bioprosthetic Heart Valve Implantation in Iran (Tehran Heart Centre Experience)
by: Ali Mohammad Haji Zeinali
Published: (2021-12-01)

Sevelamer Attenuates Bioprosthetic Heart Valve Calcification
by: Zhen Meng, et al.
Published: (2021-09-01)

The analysis of oauses of bioprosthetio valve dysfunction: the example of «UniLine» bioprosthesis
by: T. V. Glushkova, et al.
Published: (2019-07-01)

An overlooked fact: thrombocytopenia following bioprosthetic aortic valve replacement
by: Mehmet Kizilay, et al.
Published: (2019-04-01)

Cardio-Obstetrics Team-Based Management of a Pregnant Patient With Severe Bioprosthetic Aortic Valve Disease
by: Catherine Bigelow, MD, et al.
Published: (2024-02-01)

Left atrial Thrombus formation after discontinuation of anticoagulation in patient with severe bioprosthetic mitral stenosis
by: Ryan C. King, et al.
Published: (2023-12-01)

Functional non-glutaraldehyde treated porcine pericardium for anti-coagulation, anti-calcification, and endothelial proliferation bioprosthetic heart valves
by: Xiaotong Chen, et al.
Published: (2022-08-01)